Affichage des articles dont le libellé est FDA approves new drug to treat adults with advanced urothelial or bladder cancer. Afficher tous les articles
Affichage des articles dont le libellé est FDA approves new drug to treat adults with advanced urothelial or bladder cancer. Afficher tous les articles

jeudi 19 décembre 2019

FDA approves new drug to treat adults with advanced urothelial or bladder cancer

The U.S. Food & Drug Administration granted accelerated approval to the drug enfortumab vedotin (EV) to treat adult patients with advanced urothelial or bladder cancer. FDA approves new drug to treat adults with advanced urothelial or bladder cancer
Publié par à Aucun commentaire:
Libellés :
Inscription à : Commentaires (Atom)